• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器学习模型以进一步确定优势人群,这些人群在接受 Peg-IFNα 治疗后可以实现慢性乙型肝炎病毒感染的功能性治愈。

Machine learning models to further identify advantaged populations that can achieve functional cure of chronic hepatitis B virus infection after receiving Peg-IFN alpha treatment.

机构信息

Department of Infectious Disease, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Department of Radiology Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

出版信息

Int J Med Inform. 2025 Jan;193:105660. doi: 10.1016/j.ijmedinf.2024.105660. Epub 2024 Oct 22.

DOI:10.1016/j.ijmedinf.2024.105660
PMID:39454328
Abstract

OBJECTIVE

Functional cure is currently the highest goal of hepatitis B virus(HBV) treatment.Pegylated interferon(Peg-IFN) alpha is an important drug for this purpose,but even in the hepatitis B e antigen(HBeAg)-negative population,there is still a portion of the population respond poorly to it.Therefore,it is important to explore the influencing factors affecting the response rate of Peg-IFN alpha and establish a prediction model to further identify advantaged populations.

METHODS

We retrospectively analyzed 382 patients.297 patients were in the training set and 85 patients from another hospital were in the test set.The intersect features were extracted from all variables using the recursive feature elimination(RFE) algorithm, Boruta algorithm, and least absolute shrinkage and selection operator(LASSO) regression algorithm in the training dataset.Then,we employed six machine learning(ML) algorithms-Logistic Regression(LR),Random Forest(RF),Support Vector Machines(SVM),K Nearest Neighbors(KNN),Light Gradient Boosting Machine(LightGBM) and Extreme Gradient Boosting(XGBoost)-to develop the model.Internal 10-fold cross-validation helped determine the best-performing model,which was then tested externally.Model performance was assessed using metrics such as area under the curve(AUC) and other metrics.SHapley Additive exPlanations(SHAP) plots were used to interpret variable significance.

RESULTS

138/382(36.13 %) patients achieved functional cure.HBsAg at baseline,HBsAg decline at week12,non-alcoholic fatty liver disease(NAFLD) and age were identified as significant variables.RF performed the best,with AUC value of 0.988,and maintained good performance in test set.The SHapley Additive exPlanations(SHAP) plot highlighted HBsAg at baseline and HBsAg decline at week 12 are the top two predictors.The web-calculator was designed to predict functional cure more conveniently(https://www.xsmartanalysis.com/model/list/predict/model/html?mid = 17054&symbol = 317ad245Hx628ko3uW51).

CONCLUSION

We developed a prediction model,which can be used to not only accurately identifies advantageous populations with Peg-IFN alpha,but also determines whether to continue subsequent Peg-IFN alpha.

摘要

目的

功能性治愈是目前乙型肝炎病毒(HBV)治疗的最高目标。聚乙二醇干扰素(Peg-IFN)α是实现这一目标的重要药物,但即使在乙型肝炎 e 抗原(HBeAg)阴性人群中,仍有一部分人群对此反应不佳。因此,探索影响 Peg-IFN α 应答率的影响因素并建立预测模型以进一步确定优势人群非常重要。

方法

我们回顾性分析了 382 例患者。297 例患者来自训练集,85 例患者来自另一所医院的测试集。从训练数据集中使用递归特征消除(RFE)算法、Boruta 算法和最小绝对值收缩和选择算子(LASSO)回归算法提取所有变量的交集特征。然后,我们使用六种机器学习(ML)算法-逻辑回归(LR)、随机森林(RF)、支持向量机(SVM)、K 最近邻(KNN)、Light Gradient Boosting Machine(LightGBM)和极端梯度提升(XGBoost)-建立模型。内部 10 折交叉验证有助于确定表现最佳的模型,然后对其进行外部测试。使用曲线下面积(AUC)等指标评估模型性能。使用 SHapley Additive exPlanations(SHAP)图解释变量的重要性。

结果

382 例患者中,有 138 例(36.13%)达到了功能性治愈。基线 HBsAg、第 12 周 HBsAg 下降、非酒精性脂肪性肝病(NAFLD)和年龄被确定为显著变量。RF 表现最佳,AUC 值为 0.988,在测试集中也保持了良好的性能。SHapley Additive exPlanations(SHAP)图突出显示基线 HBsAg 和第 12 周 HBsAg 下降是前两个预测因素。我们设计了一个网络计算器,以更方便地预测功能性治愈(https://www.xsmartanalysis.com/model/list/predict/model/html?mid=17054&symbol=317ad245Hx628ko3uW51)。

结论

我们开发了一个预测模型,不仅可以准确识别 Peg-IFN α的优势人群,还可以确定是否继续后续的 Peg-IFN α治疗。

相似文献

1
Machine learning models to further identify advantaged populations that can achieve functional cure of chronic hepatitis B virus infection after receiving Peg-IFN alpha treatment.机器学习模型以进一步确定优势人群,这些人群在接受 Peg-IFNα 治疗后可以实现慢性乙型肝炎病毒感染的功能性治愈。
Int J Med Inform. 2025 Jan;193:105660. doi: 10.1016/j.ijmedinf.2024.105660. Epub 2024 Oct 22.
2
A predictive model for functional cure in chronic HBV patients treated with pegylated interferon alpha: a comparative study of multiple algorithms based on clinical data.聚乙二醇化干扰素α治疗慢性乙型肝炎患者功能性治愈的预测模型:基于临床数据的多种算法的比较研究
Virol J. 2024 Dec 23;21(1):333. doi: 10.1186/s12985-024-02599-1.
3
A high functional cure rate was induced by pegylated interferon alpha-2b treatment in postpartum hepatitis B e antigen-negative women with chronic hepatitis B virus infection: an exploratory study.聚乙二醇干扰素 α-2b 治疗产后乙型肝炎 e 抗原阴性慢性乙型肝炎病毒感染妇女的高功能性治愈率:一项探索性研究。
Front Cell Infect Microbiol. 2024 Aug 8;14:1426960. doi: 10.3389/fcimb.2024.1426960. eCollection 2024.
4
Using machine learning models to predict HBeAg seroconversion in CHB patients receiving pegylated interferon-α monotherapy.使用机器学习模型预测接受聚乙二醇干扰素-α单药治疗的 CHB 患者的 HBeAg 血清学转换。
J Clin Lab Anal. 2022 Nov;36(11):e24667. doi: 10.1002/jcla.24667. Epub 2022 Sep 30.
5
Clinical cure induced by pegylated interferon α-2b in the advantaged population of chronic hepatitis B virus infection: a retrospective cohort study.聚乙二醇干扰素 α-2b 在慢性乙型肝炎病毒感染优势人群中诱导的临床治愈:一项回顾性队列研究。
Front Cell Infect Microbiol. 2024 Jan 16;13:1332232. doi: 10.3389/fcimb.2023.1332232. eCollection 2023.
6
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
7
Efficacy of short-term Peg-IFN α-2b treatment in chronic hepatitis B patients with ultra-low HBsAg levels: a retrospective cohort study.短期聚乙二醇干扰素 α-2b 治疗低 HBsAg 水平慢性乙型肝炎患者的疗效:一项回顾性队列研究。
Virol J. 2024 Sep 27;21(1):231. doi: 10.1186/s12985-024-02512-w.
8
Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.聚乙二醇化干扰素α治疗经治慢性乙型肝炎患者。
PLoS One. 2015 Apr 2;10(4):e0122259. doi: 10.1371/journal.pone.0122259. eCollection 2015.
9
Triple motif proteins 19 and 38 correlated with treatment responses and HBsAg clearance in HBeAg-negative chronic hepatitis B patients during peg-IFN-α therapy.三重基序蛋白 19 和 38 与聚乙二醇干扰素-α治疗 HBeAg 阴性慢性乙型肝炎患者的治疗应答和 HBsAg 清除相关。
Virol J. 2023 Jul 20;20(1):161. doi: 10.1186/s12985-023-02119-7.
10
Application of Interpretable Machine Learning Models to Predict the Risk Factors of HBV-Related Liver Cirrhosis in CHB Patients Based on Routine Clinical Data: A Retrospective Cohort Study.基于常规临床数据应用可解释机器学习模型预测慢性乙型肝炎患者HBV相关肝硬化的危险因素:一项回顾性队列研究
J Med Virol. 2025 Mar;97(3):e70302. doi: 10.1002/jmv.70302.

引用本文的文献

1
A research protocol for a prospective, multicenter, cohort study on interferon therapy for chronic hepatitis B combined with metabolism-associated fatty liver disease to achieve clinical cure.一项关于干扰素治疗慢性乙型肝炎合并代谢相关脂肪性肝病以实现临床治愈的前瞻性、多中心队列研究的研究方案。
Front Public Health. 2025 Mar 14;13:1546182. doi: 10.3389/fpubh.2025.1546182. eCollection 2025.
2
Development and validation of an explainable machine learning model to predict Delphian lymph node metastasis in papillary thyroid cancer: a large cohort study.用于预测甲状腺乳头状癌中德尔菲淋巴结转移的可解释机器学习模型的开发与验证:一项大型队列研究
J Cancer. 2025 Mar 3;16(6):2041-2061. doi: 10.7150/jca.110141. eCollection 2025.